back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2023-12-13 20:27 Tx date 2023-06-30 |
$TH
Theratechnologies Inc. |
Weil, Dale
4 - Director of Issuer
Direct Ownership
|
Convertible Notes
38 - Redemption, retraction, cancellation, repurchase
|
$
-$2,000 vol $1.00 each |
$0 | |
| Filed 2023-11-04 11:11 Tx date 2023-11-01 |
$TH
Theratechnologies Inc. |
Weil, Dale
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$49,955
+36,200 vol $1.38 each |
44,160 | |
| Filed 2023-11-04 11:08 Tx date 2023-07-31 |
$TH
Theratechnologies Inc. |
Weil, Dale
4 - Director of Issuer
Direct Ownership
|
Common Shares
37 - Stock split or consolidation
|
-23,880 vol |
7,960 | |
| Filed 2023-03-02 19:07 Tx date 2023-02-28 |
$TH
Theratechnologies Inc. |
Weil, Dale
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+21,739 vol |
90,913 | |
| Filed 2022-05-20 13:47 Tx date 2022-05-18 |
$MRV
Nuvo Pharmaceuticals Inc. (d/b/a Miravo Healthcare) |
Weil, Dale
4 - Director of Issuer
Direct Ownership
|
Deferred Share Unit Plan (DSU)
56 - Grant of rights
|
+36,340 vol |
36,340 | |
| Filed 2022-05-20 13:46 Tx date 2022-05-16 |
$MRV
Nuvo Pharmaceuticals Inc. (d/b/a Miravo Healthcare) |
Weil, Dale
4 - Director of Issuer
Direct Ownership
|
Deferred Share Unit Plan (DSU)
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2021-12-04 17:54 Tx date 2021-12-01 |
$TH
Theratechnologies Inc. |
Weil, Dale
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$59,655
+14,170 vol $4.21 each |
69,174 | |
| Filed 2021-10-28 12:45 Tx date 2021-10-25 |
$TH
Theratechnologies Inc. |
Weil, Dale
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$46,068
+10,470 vol $4.40 each |
31,840 | |
| Filed 2021-10-28 12:42 Tx date 2021-10-25 |
$TH
Theratechnologies Inc. |
Weil, Dale
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$4,390
+1,000 vol $4.39 each |
21,370 | |
| Filed 2021-10-28 12:40 Tx date 2021-10-25 |
$TH
Theratechnologies Inc. |
Weil, Dale
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$16,001
+3,670 vol $4.36 each |
20,370 | |
| Filed 2021-10-28 08:37 Tx date 2021-10-25 |
$TH
Theratechnologies Inc. |
Weil, Dale
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$50,353
+11,470 vol $4.39 each |
28,170 | |
| Filed 2021-10-28 08:37 Tx date 2021-10-25 |
$TH
Theratechnologies Inc. |
Weil, Dale
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$50,353
+11,470 vol $4.39 each |
||
| Filed 2021-06-02 12:58 Tx date 2021-05-28 |
$TBP
Tetra Bio-Pharma Inc. |
Weil, Dale
4 - Director of Issuer
Direct Ownership
|
Rights Deferred Share Units
56 - Grant of rights
|
+140,845 vol |
140,845 | |
| Filed 2021-06-01 23:24 Tx date 2021-05-28 |
$TBP
Tetra Bio-Pharma Inc. |
Weil, Dale
4 - Director of Issuer
Direct Ownership
|
Rights Deferred Share Units
56 - Grant of rights
|
+50,000 vol |
||
| Filed 2021-06-01 19:59 Tx date 2021-05-28 |
$TBP
Tetra Bio-Pharma Inc. |
Weil, Dale
4 - Director of Issuer
Direct Ownership
|
Rights Deferred Share Units
56 - Grant of rights
|
+50,000 vol |
||
| Filed 2021-06-01 19:59 Tx date 2021-05-28 |
$TBP
Tetra Bio-Pharma Inc. |
Weil, Dale
4 - Director of Issuer
Direct Ownership
|
Rights Deferred Share Units
56 - Grant of rights
|
+50,000 vol |
50,000 | |
| Filed 2021-06-01 19:53 Tx date 2020-09-14 |
$TBP
Tetra Bio-Pharma Inc. |
Weil, Dale
4 - Director of Issuer
Direct Ownership
|
Rights Deferred Share Units
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2021-03-15 12:15 Tx date 2021-03-10 |
$TBP
Tetra Bio-Pharma Inc. |
Weil, Dale
4 - Director of Issuer
Direct Ownership
|
Common Shares deferred share unit
56 - Grant of rights
|
$49,999
+263,157 vol $0.19 each |
263,157 | |
| Filed 2021-03-15 12:10 Tx date 2020-09-14 |
$TBP
Tetra Bio-Pharma Inc. |
Weil, Dale
4 - Director of Issuer
Direct Ownership
|
Common Shares deferred share unit
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2021-03-02 21:53 Tx date 2021-02-26 |
$TH
Theratechnologies Inc. |
Weil, Dale
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$52,103
+13,258 vol $3.93 each |
55,004 | |
| Filed 2021-02-28 13:55 Tx date 2021-02-25 |
$TH
Theratechnologies Inc. |
Weil, Dale
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$92,400
+35,000 vol $2.64 each |
||
| Filed 2021-02-26 18:34 Tx date 2021-02-25 |
$TH
Theratechnologies Inc. |
Weil, Dale
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$92,400
+35,000 vol $2.64 each |
||
| Filed 2021-02-28 13:55 Tx date 2021-02-25 |
$TH
Theratechnologies Inc. |
Weil, Dale
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$92,400
+35,000 vol $2.64 each |
76,746 | |
| Filed 2021-02-26 18:34 Tx date 2021-02-25 |
$TH
Theratechnologies Inc. |
Weil, Dale
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$92,400
+35,000 vol $2.64 each |
||
| Filed 2021-02-26 18:34 Tx date 2021-02-25 |
$TH
Theratechnologies Inc. |
Weil, Dale
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$92,400
+35,000 vol $2.64 each |
76,746 | |
| Filed 2020-02-26 10:19 Tx date 2020-02-26 |
$TH
Theratechnologies Inc. |
Weil, Dale
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$34,132
+10,600 vol $3.22 each |
41,746 | |
| Filed 2019-10-18 14:22 Tx date 2019-10-15 |
$TH
Theratechnologies Inc. |
Weil, Dale
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$30,069
+6,200 vol $4.85 each |
16,700 | |
| Filed 2019-10-18 14:21 Tx date 2019-10-15 |
$TH
Theratechnologies Inc. |
Weil, Dale
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$38,535
+10,500 vol $3.67 each |
10,500 | |
| Filed 2019-10-18 14:19 Tx date 2017-05-16 |
$TH
Theratechnologies Inc. |
Weil, Dale
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2019-05-09 15:39 Tx date 2019-05-07 |
$TH
Theratechnologies Inc. |
Weil, Dale
4 - Director of Issuer
Direct Ownership
|
Unités d'actions différées (DSU)
56 - Grant of rights
|
$7,501
+1,055 vol $7.11 each |
5,531 | |
| Filed 2019-02-26 Tx date 2019-02-26 |
$TH
Theratechnologies Inc. |
Weil, Dale
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$77,964
+8,900 vol $8.76 each |
31,146 | |
| Filed 2018-10-29 Tx date 2018-10-26 |
$TH
Theratechnologies Inc. |
Weil, Dale
4 - Director of Issuer
Direct Ownership
|
Unités d'actions différées (DSU)
56 - Grant of rights
|
$7,497
+1,027 vol $7.30 each |
4,476 | |
| Filed 2018-08-02 Tx date 2018-08-01 |
$TH
Theratechnologies Inc. |
Weil, Dale
4 - Director of Issuer
Direct Ownership
|
Unités d'actions différées (DSU)
56 - Grant of rights
|
$33,269
+3,449 vol $9.65 each |
||
| Filed 2018-08-02 Tx date 2018-08-01 |
$TH
Theratechnologies Inc. |
Weil, Dale
4 - Director of Issuer
Direct Ownership
|
Unités d'actions différées (DSU)
56 - Grant of rights
|
$14,999
+1,555 vol $9.65 each |
3,449 | |
| Filed 2018-06-22 Tx date 2017-05-16 |
$TH
Theratechnologies Inc. |
Weil, Dale
4 - Director of Issuer
Direct Ownership
|
Convertible Notes
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2018-06-22 Tx date 2018-06-19 |
$TH
Theratechnologies Inc. |
Weil, Dale
4 - Director of Issuer
Direct Ownership
|
Convertible Notes
15 - Acquisition or disposition under a prospectus
|
+$2,000 vol |
$2,000 | |
| Filed 2018-04-07 Tx date 2018-04-06 |
$TH
Theratechnologies Inc. |
Weil, Dale
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+7,246 vol |
22,246 | |
| Filed 2017-10-20 Tx date 2017-05-16 |
$TH
Theratechnologies Inc. |
Weil, Dale
4 - Director of Issuer
Direct Ownership
|
Unités d'actions différées (DSU)
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2017-10-20 Tx date 2017-10-16 |
$TH
Theratechnologies Inc. |
Weil, Dale
4 - Director of Issuer
Direct Ownership
|
Unités d'actions différées (DSU)
56 - Grant of rights
|
$15,000
+1,894 vol $7.92 each |
1,894 | |
| Filed 2017-05-18 Tx date 2017-05-16 |
$TH
Theratechnologies Inc. |
Weil, Dale
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+15,000 vol |
15,000 | |
| Filed 2017-05-18 Tx date 2017-05-16 |
$TH
Theratechnologies Inc. |
Weil, Dale
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|